NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

NEW YORK CITY, NY / ACCESS Newswire / March 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.

Shakir spent three years at Mazzoni, overseeing major initiatives to boost the agency's finances, but also a cash crunch that ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...